Lonafarnib
Lonafarnib
Definition
A synthetic tricyclic derivative of carboxamide with antineoplastic properties. Lonarfanib binds to and inhibits farnesyl transferase, an enzyme involved in the post-translational modification and activation of Ras proteins. Ras proteins participate in numerous signalling pathways (proliferation, cytoskeletal organization), and play an important role in oncogenesis. Mutated ras proteins have been found in a wide range of human cancers. (NCI04)
Also known as 4-[2-[4-(3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide, 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide, LONAFARNIB, Sarasar, SCH 66336, SCH-66336, SCH66336 — per NCIT
Also identified as
- ATC A16AX20 per RXNORM
- NCIT NCIT:C1829 per NCIT
- SCTID 1137365008 per RXNORM
- SCTID 1137617003 per RXNORM
- UNII IOW153004F per RXNORM